Interestingly, a recent study demonstrated that CD4+ but not CD8+ T-cells from peripheral blood of MS patients expressed NKG2C and had elevated levels of cytotoxic molecules FasL, granzyme B, and perforin. The gene discussed is CD8A; the disease is myeloid sarcoma.